Diallyl trisulfide (DATS) ameliorates cardiac fibrosis in a rat model of diabetes

Cardiac fibrosis is a prevalent pathological complication observed in individuals with diabetes. Diallyl trisulfide (DATS), a bioactive compound found in garlic oil, has been reported to exhibit anti-inflammatory and anti-apoptotic effects in various cardiovascular diseases. However, its potential i...

Full description

Bibliographic Details
Main Authors: Dennis Jine-Yuan Hsieh, Shang-Chuan Ng, Shang-Yeh Lu, Yen-Tun Chiu, Kuan-Ho Lin, Yueh-Min Lin, Chih-Yang Huang, Wei-Wen Kuo
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464623005017
_version_ 1827620857986416640
author Dennis Jine-Yuan Hsieh
Shang-Chuan Ng
Shang-Yeh Lu
Yen-Tun Chiu
Kuan-Ho Lin
Yueh-Min Lin
Chih-Yang Huang
Wei-Wen Kuo
author_facet Dennis Jine-Yuan Hsieh
Shang-Chuan Ng
Shang-Yeh Lu
Yen-Tun Chiu
Kuan-Ho Lin
Yueh-Min Lin
Chih-Yang Huang
Wei-Wen Kuo
author_sort Dennis Jine-Yuan Hsieh
collection DOAJ
description Cardiac fibrosis is a prevalent pathological complication observed in individuals with diabetes. Diallyl trisulfide (DATS), a bioactive compound found in garlic oil, has been reported to exhibit anti-inflammatory and anti-apoptotic effects in various cardiovascular diseases. However, its potential impact on cardiac fibrosis, particularly in the context of diabetes, remains unknown. In the neonatal rat ventricular fibroblasts (NRVFs) model, our results demonstrated that DATS effectively attenuated advanced glycation end products (AGEs)-induced activation of Nuclear factor kappa B (NF-κB) and Smad2/3 signaling pathways, leading to a reduction in the downstream secretion of pro-inflammatory cytokines and collagen synthesis. In the in vivo study using echocardiographic assessment, administration of DATS significantly ameliorated cardiac dysfunction induced by streptozotocin (STZ). Taken together, our findings highlight the potential of DATS as a promising therapeutic agent for mitigating cardiac fibrosis associated with diabetes, emphasizing its potential clinical relevance in the prevention and management of diabetic cardiomyopathy.
first_indexed 2024-03-09T10:53:51Z
format Article
id doaj.art-ef4172a961aa40c1929b02fe526943eb
institution Directory Open Access Journal
issn 1756-4646
language English
last_indexed 2024-03-09T10:53:51Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Journal of Functional Foods
spelling doaj.art-ef4172a961aa40c1929b02fe526943eb2023-12-01T05:01:14ZengElsevierJournal of Functional Foods1756-46462023-12-01111105901Diallyl trisulfide (DATS) ameliorates cardiac fibrosis in a rat model of diabetesDennis Jine-Yuan Hsieh0Shang-Chuan Ng1Shang-Yeh Lu2Yen-Tun Chiu3Kuan-Ho Lin4Yueh-Min Lin5Chih-Yang Huang6Wei-Wen Kuo7School of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan, ROC; Clinical Laboratory, Chung Shan Medical University Hospital, Taichung 402, Taiwan, ROCDepartment of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung 406, Taiwan, ROC; Ph.D. Program for Biotechnology Industry, China Medical University, Taichung 406, Taiwan, ROCDivision of Cardiovascular Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan, ROC; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, ROCDepartment of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung 406, Taiwan, ROC; Ph.D. Program for Biotechnology Industry, China Medical University, Taichung 406, Taiwan, ROCCollege of Medicine, China Medical University, Taichung 404, Taiwan, ROC; Department of Emergency Medicine, China Medical University Hospital, Taichung 404, Taiwan, ROCDepartment of Surgical Pathology, Changhua Christian Hospital, Changhua 500, Taiwan, ROC; School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan, ROC; Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung 406, Taiwan, ROCGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, ROC; Cardiovascular and Mitochondrial Related Disease Research Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan, ROC; Center of General Education, Buddhist Tzu Chi Medical Foundation, Tzu Chi University of Science and Technology, Hualien 970, Taiwan, ROC; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan, ROC; Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung 413, Taiwan, ROCDepartment of Biological Science and Technology, College of Life Sciences, China Medical University, Taichung 406, Taiwan, ROC; Ph.D. Program for Biotechnology Industry, China Medical University, Taichung 406, Taiwan, ROC; Corresponding author at: Dept. of Biological Science & Technology, School of Life Science, China Medical University, No. 91, Hsueh-Shih Road, Taichung 40402, Taiwan, ROC (W.-W. Kuo).Cardiac fibrosis is a prevalent pathological complication observed in individuals with diabetes. Diallyl trisulfide (DATS), a bioactive compound found in garlic oil, has been reported to exhibit anti-inflammatory and anti-apoptotic effects in various cardiovascular diseases. However, its potential impact on cardiac fibrosis, particularly in the context of diabetes, remains unknown. In the neonatal rat ventricular fibroblasts (NRVFs) model, our results demonstrated that DATS effectively attenuated advanced glycation end products (AGEs)-induced activation of Nuclear factor kappa B (NF-κB) and Smad2/3 signaling pathways, leading to a reduction in the downstream secretion of pro-inflammatory cytokines and collagen synthesis. In the in vivo study using echocardiographic assessment, administration of DATS significantly ameliorated cardiac dysfunction induced by streptozotocin (STZ). Taken together, our findings highlight the potential of DATS as a promising therapeutic agent for mitigating cardiac fibrosis associated with diabetes, emphasizing its potential clinical relevance in the prevention and management of diabetic cardiomyopathy.http://www.sciencedirect.com/science/article/pii/S1756464623005017Diallyl trisulfide (DATS)FibrosisDiabetic mellitus (Hsieh et al.)NFκBSmad2/3
spellingShingle Dennis Jine-Yuan Hsieh
Shang-Chuan Ng
Shang-Yeh Lu
Yen-Tun Chiu
Kuan-Ho Lin
Yueh-Min Lin
Chih-Yang Huang
Wei-Wen Kuo
Diallyl trisulfide (DATS) ameliorates cardiac fibrosis in a rat model of diabetes
Journal of Functional Foods
Diallyl trisulfide (DATS)
Fibrosis
Diabetic mellitus (Hsieh et al.)
NFκB
Smad2/3
title Diallyl trisulfide (DATS) ameliorates cardiac fibrosis in a rat model of diabetes
title_full Diallyl trisulfide (DATS) ameliorates cardiac fibrosis in a rat model of diabetes
title_fullStr Diallyl trisulfide (DATS) ameliorates cardiac fibrosis in a rat model of diabetes
title_full_unstemmed Diallyl trisulfide (DATS) ameliorates cardiac fibrosis in a rat model of diabetes
title_short Diallyl trisulfide (DATS) ameliorates cardiac fibrosis in a rat model of diabetes
title_sort diallyl trisulfide dats ameliorates cardiac fibrosis in a rat model of diabetes
topic Diallyl trisulfide (DATS)
Fibrosis
Diabetic mellitus (Hsieh et al.)
NFκB
Smad2/3
url http://www.sciencedirect.com/science/article/pii/S1756464623005017
work_keys_str_mv AT dennisjineyuanhsieh diallyltrisulfidedatsamelioratescardiacfibrosisinaratmodelofdiabetes
AT shangchuanng diallyltrisulfidedatsamelioratescardiacfibrosisinaratmodelofdiabetes
AT shangyehlu diallyltrisulfidedatsamelioratescardiacfibrosisinaratmodelofdiabetes
AT yentunchiu diallyltrisulfidedatsamelioratescardiacfibrosisinaratmodelofdiabetes
AT kuanholin diallyltrisulfidedatsamelioratescardiacfibrosisinaratmodelofdiabetes
AT yuehminlin diallyltrisulfidedatsamelioratescardiacfibrosisinaratmodelofdiabetes
AT chihyanghuang diallyltrisulfidedatsamelioratescardiacfibrosisinaratmodelofdiabetes
AT weiwenkuo diallyltrisulfidedatsamelioratescardiacfibrosisinaratmodelofdiabetes